Brandi L. Roberts
Chief Financial Officer
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Definium Therapeutics, Inc. (DFTX) | Chief Financial Officer | $288,750 | $5,116,362 |
Executive changes
Earnings-call appearances
-
Definium Therapeutics, Inc. Q1 FY2026 Earnings Call2026-05-07
Definium Therapeutics, Inc. (DFTX)
-
Definium Therapeutics, Inc. Q4 FY2025 Earnings Call2026-02-26
Definium Therapeutics, Inc. (DFTX)
-
Definium Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-06
Definium Therapeutics, Inc. (DFTX)
-
Definium Therapeutics, Inc. Q2 FY2025 Earnings Call2025-07-31
Definium Therapeutics, Inc. (DFTX)